{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Sensus Healthcare, Inc.
Sensus Healthcare Stock Plummets to New 52-Week Low of $2.68
Sensus Healthcare, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant decline in stock price. The company reported a net loss of nearly USD 5.79 million and has experienced negative results for five consecutive quarters, indicating ongoing financial difficulties.
Sensus Healthcare Stock Hits New 52-Week Low at $2.85
Sensus Healthcare, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported a 62.2% drop in net sales and a negative return on equity, alongside rising raw material costs, indicating ongoing financial challenges.
Is Sensus Healthcare, Inc. technically bullish or bearish?
As of August 8, 2025, Sensus Healthcare, Inc. is in a bearish trend, supported by bearish MACD, Bollinger Bands, and moving averages, with mixed signals from other indicators.
Is Sensus Healthcare, Inc. overvalued or undervalued?
As of August 7, 2025, Sensus Healthcare, Inc. is considered risky and overvalued due to its high P/E ratio of 45 and EV to EBITDA of 20.70, which are significantly higher than its peers like Kewaunee Scientific Corp., while its low ROCE of 7.47% and ROE of 3.40% do not justify its valuation.
Is Sensus Healthcare, Inc. overvalued or undervalued?
As of May 15, 2025, Sensus Healthcare, Inc. is considered overvalued with a P/E ratio of 45 and an EV to EBITDA of 20.70, significantly higher than industry averages and its peers, indicating a shift in market perception from very attractive to expensive.
Is Sensus Healthcare, Inc. technically bullish or bearish?
As of May 13, 2025, Sensus Healthcare, Inc. shows a mildly bearish trend with mixed signals from key indicators, including a mildly bullish weekly MACD and bearish monthly MACD, alongside bearish Bollinger Bands and moving averages.
Who are in the management team of Sensus Healthcare, Inc.?
As of March 2022, the management team of Sensus Healthcare, Inc. includes Chairman and CEO Joseph Sardano, Directors Megan Cornish and Anthony Petrelli, and Non-Executive Independent Directors John Heinrich, William McCall, and Samuel O'Rear. They are responsible for the company's strategic direction and operations.
What does Sensus Healthcare, Inc. do?
Sensus Healthcare, Inc. is a medical device company specializing in non-invasive treatments for skin conditions, with recent net sales of $8 million and a market cap of $79.64 million. The company reported a net profit of -$3 million for the quarter ending March 2025.
How big is Sensus Healthcare, Inc.?
As of Jun 18, Sensus Healthcare, Inc. has a market capitalization of 79.64 million, with net sales of 39.49 million and a net profit of 1.81 million over the latest four quarters. The balance sheet shows shareholder's funds of 55.83 million and total assets of 62.19 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
